Valuation: Medinotec Inc.

Market Cap 58.67M 52.54M 48.33M 43.79M 81.86M 5.57B 83.39M 576M 231M 2.93B 220M 215M 9.24B P/E 2025
27.2x
P/E 2026 74x
Enterprise Value 55.93M 50.09M 46.07M 41.75M 78.03M 5.31B 79.49M 549M 221M 2.79B 210M 205M 8.81B EV / Sales 2025
6,241,228x
EV / Sales 2026 5,748,224x
Free-Float
15.57%
Yield 2025 *
-
Yield 2026 -
3 years 5
Extreme 5
5
5 years 5
Extreme 5
5
10 years 5
Extreme 5
5
Manager TitleAgeSince
Chief Executive Officer 47 25/04/2021
Director of Finance/CFO 40 25/04/2021
Director TitleAgeSince
Chairman 47 -
Director/Board Member 55 12/06/2022
Director/Board Member 69 12/06/2022
Date Insider Type Main position Quantity % Market Cap. Importance
16/04/25 Other

Director

12,073 0.1029%
16/04/25 Other

Director

0 0%
16/04/25 Other

Chief Financial Officer

401,965 3.4257%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-.--% 58.67M
+1.56%+2.41%-14.82%+14.19% 181B
-6.38%-4.98%-20.90%+11.15% 120B
-0.59%+1.18%+6.12%+37.97% 119B
+3.42%+4.04%-42.10%+9.69% 91.44B
+0.09%-0.05%-3.04%+78.44% 63.07B
-0.46%-0.64%+9.87%+80.82% 55.8B
-0.23%-0.52%+10.31%-21.19% 54.03B
-4.30%-1.64%-12.30%+39.06% 45.38B
+0.58%+2.18%-0.54%-6.40% 34.37B
Average -0.80%+0.43%-6.74%+24.37% 76.35B
Weighted average by Cap. -0.75%+0.76%-10.43%+25.10%

Financials

2025 2026
Net sales 9.11 8.16 7.51 6.8 12.72 865.34 12.95 89.53 35.94 455.2 34.2 33.48 1.44K 9.73 8.71 8.02 7.26 13.58 923.82 13.83 95.58 38.37 485.96 36.51 35.74 1.53K
Net income 2.16M 1.93M 1.78M 1.61M 3.01M 205M 3.07M 21.21M 8.52M 108M 8.1M 7.93M 340M 795K 712K 655K 593K 1.11M 75.44M 1.13M 7.81M 3.13M 39.68M 2.98M 2.92M 125M
Net Debt -1.79M -1.6M -1.47M -1.34M -2.5M -170M -2.54M -17.57M -7.05M -89.34M -6.71M -6.57M -282M -2.74M -2.46M -2.26M -2.05M -3.83M -260M -3.9M -26.93M -10.81M -137M -10.29M -10.07M -432M
Projected Income Statement - Annual - Medinotec Inc.
Logo Medinotec Inc.
Medinotec Inc., through its primary investment in DISA Medinotec Proprietary Limited, is engaged in medical device manufacturing and distribution. The Company’s segments include Sales Outside the United States and Domestic Sales. The Sales Outside the United States segment includes both internally developed products and third-party products distributed under agreement. The Domestic Sales segment focuses on the proprietary Trachealator product within the United States. The Company manufactures and distributes medical devices that focus on tracheal non-occlusive airway dilatation technology. Its products include Trachealator, Cape Cross PTCA Catheter, Cape Cross Non-Compliant Catheter, Aortic Valve Dilatation Balloon Catheter, and Micro CTO Catheter. The products developed are sold through a network of distributors in many parts of the world and through a direct sales force in South Africa and the United States of America.
Employees
36
  1. Stock Market
  2. Stocks
  3. MDNC Stock